• Festival of Biologics

    Basel , Schweiz

    Mattias Levin, PhD, Senior Team Manager, Antibody Engineering, at Alligator Bioscience, will give a presentation entitled "Neo-X-Prime™: Bispecific Tumor Antigen Conditional CD40 Agonistic Antibodies" at 5:00 pm CET on November […]

  • SITC (Society for Immunotherapy of Cancer) 2022

    Boston Boston, Massachusetts, Förenta Staterna, USA

    Malin Lindstedt, visiting professor at Alligator Bioscience and Professor at the Department of Immunotechnology at Lund University, will give a poster presentation entitled “Early pharmacodynamic changes measured by RNA sequencing […]

  • Redeye Life Science Day, Stockholm

    Virtuellt

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

  • Biostock Life Science Fall Summit 2022

    Medicon Village Medicon Village, Lund, Sverige

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will give a corporate presentation followed by a Q&A session at 1:00 pm CET on November 30.

  • 13th Annual DNB Nordic Healthcare Conference

    Oslo Oslo, Norge

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

  • ØU Life Science Investor Conference

    Köpenhamn Köpenhamn, Danmark

    Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

  • European Bispecific & Multispecific Antibody Congress

    Amsterdam Amsterdam, Nederländerna

    Laura von Schantz, Vice President of Discovery at Alligator Bioscience, will give a presentation entitled "Reviewing the Landscape of Obligate MoAs for Bi-/Multispecifics to Prioritise and De-Risk Current and Future Efforts" at […]